Quinidine Drug: Indication, Dosage, Precaution, Side Effect , Storage, Category Type and corresponding Brands - www.genericdrugscan.com
Quinidine
Drug Status in USA : ApprovedDrug Status in Canada : Approved
Indication : Why is this medication prescribed?
Atrial and ventricular arhythmias. Maintenance of sinus rhythm following electro conversion. II line of drug for uncomplicated plasmodium falciparum malaria.Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patientHypersensitivity. Myasthenia gravis. Complete heart block, digitalis intoxication, hypotension and CHF.
Other Precaution to be observed while taking this medication
Atrial flutter, widening QRS complex, incomplete AV block, uncompensated heart failure, acute infections, fever, digitalised patients, hypokalaemia, acute MI, renal or hepatic impairment, elderly. Prolonged QT interval. Pregnancy and lactation.What are possible side effects of this medication ?
Higher doses can cause A.V. dissociation, nausea, vomiting, diarhhoea, cinchonism (ringing in ear, deafness vertigo, headache, visual disturbance) angioedema, asthma and vascular collapse. Fibrillation. Thrombocytopenia. Exfoliative. Torsads De Pointes.Drug Category/Class
- Anti-Arrhythmia Agents
- Muscarinic Antagonists
- Voltage-Gated Sodium Channel Blockers
- Adrenergic alpha-Antagonists
- Cardiovascular System
- Antiarrhythmics, Class I and Iii
- Cardiac Therapy
- Antiarrythmics, Class I and Iii
- Antiarrhythmics, Class Ia
- BSEP
- ABCB11 Inhibitors
- Antimalarials
- CYP2E1 Inhibitors
- CYP2E1 Inducers
- CYP2E1 Inducers (strong)
- Combined Inhibitors of CYP3A4 and
| Prescribed | For the treatment of ventricular pre-excitation and cardiac dysrhythmias |
| Weight : | 324.4168 |
| Structure | Quinidine |
 | |
| Formula | C20H24N2O2 |
Quinidine has 2 Brands listed
| Natcardine (100 mg) | Quinidine (200 mg) |